1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NACC2 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA AADACL2 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA IGFBP4 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA RP11-463D19.2 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA MMS22L CTRPv2 pan-cancer AAC -0.091 0.01
mRNA MSH2 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA AKAP8 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA FAM180A CTRPv2 pan-cancer AAC -0.091 0.01
mRNA ANKRD6 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA KIZ CTRPv2 pan-cancer AAC 0.091 0.01
Download CSV